The Private Equity Growth Blind Spot

Brian Shea

10 minutes ago

15 min read

Six years. Multiple CEOs. Repeated restructuring. What if the revenue engine is still arriving too late?

By Brian Shea | Founder, Lucrum Partners

There is a software development company I know well that private equity managing directors should pay attention to. The company was acquired approximately six years ago. Since then, it has cycled through multiple CEOs, three or four chief revenue officers, repeated cost reductions, and considerable commercial disruption. Most recently, the company began dismantling much of its marketing leadership. The apparent reason? Marketing was not generating enough qualified leads.

Think about that for a moment.

Six years of ownership. Multiple executive replacements. Repeated cost interventions. And the diagnosis of the company's growth problem still comes down to insufficient lead generation.

I am not suggesting that the company's leadership changes were unwarranted or that its marketing organization was performing effectively. Those conclusions would require a detailed examination of its financial performance, market position, customer relationships, and commercial operations.

But the pattern raises a question that belongs in every private equity boardroom.

At what point does a sponsor stop questioning the performance of the executives and start questioning the commercial operating system those executives have inherited?

And at what point does the portfolio CEO challenge the board to examine whether the company's growth expectations are supported by the capabilities required to deliver them?

Private equity has become increasingly sophisticated in financial governance, operational improvement, and executive talent.

Yet a portfolio company can have experienced executives, rigorous financial controls, and disciplined sales management while still lacking visibility into the customer activity that will determine its future revenue.

That is the blind spot.

The company may be managing the opportunities it can see while competitors are identifying and influencing demand that has not yet entered its pipeline.

The sponsor may be reviewing accurate financial and commercial reports without recognizing that those reports describe only a portion of the addressable revenue opportunity.

And when growth falls short, both organizations may respond by changing the people or resources operating a system that was never designed to identify demand early enough.

The fundamental question is whether the sponsor and its portfolio executives are fixing the cause of revenue underperformance or repeatedly paying to manage its symptoms.

1. Private equity has evolved. Has commercial governance kept pace?

Private equity's operating model has changed considerably over the past several decades.

Historically, many buyout firms concentrated on acquisition economics, capital structure, financial discipline, and management oversight. Portfolio-company executives carried primary responsibility for delivering operating performance.

As competition for acquisitions intensified, sponsors expanded their involvement in the businesses they owned.

They introduced more active governance, built operating groups, and recruited experienced executives and functional specialists to accelerate value creation.

Today, many firms have access to finance executives, operating partners, transformation specialists, technology advisers, and former C-suite leaders who can introduce capabilities that portfolio companies may not otherwise possess.

That evolution continues.

McKinsey reported in 2026 that private equity firms had more than doubled the average size of their operating groups since 2021, while expanding specialized capabilities and involving operating teams earlier in the investment lifecycle.

The economic environment has also changed.

Bain's 2026 Global Private Equity Report emphasizes that the industry's traditional reliance on inexpensive debt and multiple expansion is no longer sufficient to support the returns investors expect. Sponsors face greater pressure to deliver EBITDA growth through deliberate, data-backed value creation.

Private equity has responded by strengthening its ability to improve the businesses it acquires.

But commercial growth presents a different challenge. Financial performance can be measured through accounting systems. Operational efficiency can be assessed through productivity, utilization, and cost structures. Revenue growth depends on decisions made by customers outside the portfolio company's direct control.

Those customers may be developing business cases, evaluating alternatives, establishing supplier preferences, and consulting trusted advisers long before they engage the company's sales organization.

A portfolio company can have an experienced CEO, a capable CFO, a sophisticated CRM, and a disciplined sales organization while still being structurally late to the buyer's decision.

To be clear, many private equity firms already have commercial operating partners, go-to-market advisers, and revenue-growth specialists.

The issue is not necessarily the absence of commercial expertise. It is whether that expertise is consistently applied to identifying and influencing demand before it becomes visible through conventional lead generation and CRM reporting.

That is a different commercial capability, and it deserves a place in the value-creation plan.

2. The economics of another missed growth plan

The consequences of commercial underperformance extend beyond the next quarterly forecast.

McKinsey's 2026 research reports that average private equity holding periods have reached 6.6 years. It also estimates that approximately 16,000 buyout-backed companies had been held for more than four years as of 2025, representing 52% of the global buyout-backed inventory.

For a managing director overseeing an asset approaching its sixth year of ownership, the implications are significant. An additional year of ownership can mean delayed capital realization, continued financing costs, further exposure to market conditions, and more time spent attempting to deliver the original investment thesis.

Now consider a portfolio company that repeatedly misses its organic growth targets.

Management responds by reducing expenses, consolidating functions, or restructuring the commercial organization. Those actions may improve near-term EBITDA. But what happens if the company eliminates the capabilities needed to identify emerging customer demand, develop executive relationships, or expand strategic accounts? The board may see an improvement in operating expenses while the company's future revenue-generating capacity deteriorates.

This is not an argument against cost discipline. It is an argument for understanding which commercial capabilities contribute to future revenue before deciding where to reduce investment.

For the portfolio CEO, the challenge is delivering current-year commitments while preserving the capabilities needed to develop next year's revenue.

For the managing director, the question is whether the sponsor's interventions are improving the long-term economics of the investment or simply reducing the cost of an operating model that remains structurally unchanged. Neither executive can answer that question through EBITDA reporting alone.

3. What if the board is asking the wrong questions?

A private equity managing director sits through another quarterly business review.

Revenue is below plan. Pipeline coverage has deteriorated. Marketing has missed its qualified-lead target.

The CRO explains that sales needs more opportunities.
The board asks management what it intends to do about it.

The response is familiar: improve demand generation, increase sales activity, tighten qualification, and hold the commercial leadership team accountable.

Those actions may be necessary.

But what if the company's most significant revenue problem is not represented in the report?

What if potential customers are experiencing business changes that create demand for the portfolio company's services, but the commercial organization has no systematic way to identify those changes?

What if competitors are establishing executive relationships and influencing purchasing requirements months before those opportunities become visible in CRM?

What if the company is investing heavily in converting prospects who have already developed a preference for another supplier?

And what if the board has spent six years reviewing the performance of a revenue engine without ever assessing its ability to identify demand before the buyer enters the pipeline?

The financial reports may be accurate. The forecast may faithfully reflect management's assumptions. The CRO may be providing a reasonable assessment of the opportunities available to the sales organization. But none of that necessarily reveals the commercial opportunities the company failed to identify. A portfolio company can be financially well governed and commercially blind. Until the sponsor understands the difference, another executive replacement may simply restart the same cycle.

4. The buyer research that should change the portfolio review

The commercial problem becomes clearer when we examine how B2B customers make purchasing decisions.

Research conducted by Bain and Google, published in Harvard Business Review in 2022, examined the purchasing behavior of 1,208 people at U.S. companies across several B2B categories, including software and cloud services. It highlighted the importance of suppliers being considered early in the buyer's decision process.

Forrester's 2025 Buyers' Journey Survey found that 68% of surveyed B2B buyers already had a front-runner vendor in mind at the beginning of their purchasing process.

And Forrester's January 2026 research, based on nearly 18,000 global business buyers surveyed in 2025, found that the typical buying decision involved 13 internal stakeholders and nine external participants.

These studies examine different buyer populations and purchasing behaviors. They do not establish that every software development purchase follows the same process or that earlier engagement guarantees a sale. But they raise an important commercial question.

If customers are developing supplier preferences before formally engaging sales, how much of a portfolio company's commercial investment is directed toward influencing those preferences?

Consider how many companies manage their revenue organizations.

Marketing is measured on qualified-lead production.
Sales is measured on opportunity creation and conversion.
The CRO reports pipeline coverage, deal progression, and forecast confidence.
The board reviews the results.
But who is accountable for identifying customers whose business conditions are changing before those customers become leads?
Who is responsible for ensuring that the portfolio company is considered when the buyer first recognizes a problem?
Who can demonstrate that the company is gaining access to the executives responsible for authorizing the investment?
And where does any of this appear in the value-creation plan?

If management cannot answer those questions, generating another thousand leads may simply create a larger pool of late-stage selling activity. The absence of qualified leads is not necessarily the underlying problem. It may be evidence that the company has been absent from the buyer's decision process for months.

That is a very different diagnosis.

5. MQLs and SQLs: A warning sign hiding in plain sight

I would pay particular attention to a portfolio company whose explanation for revenue underperformance consistently begins with insufficient marketing-qualified leads or sales-qualified leads. Not because these metrics are inherently flawed. They can provide useful information about engagement, qualification, handoffs, and conversion.

The warning sign appears when management cannot explain future demand beyond those conventional funnel measures. An MQL tells you that an individual or account has met the company's predefined marketing qualification criteria. It does not establish that the buying organization has an urgent business problem, an approved initiative, executive sponsorship, or a commitment to purchase.

An SQL may indicate that a prospect has met sales qualification criteria.

It does not necessarily establish that the buying organization has aligned around a business case, agreed on investment priorities, or committed to a purchasing timetable.

Consider a software development firm pursuing an application modernization opportunity.

The technology executive may be interested in modernizing legacy applications.

But the CFO may have competing capital priorities. The business unit may not have established the financial case. Procurement may already be evaluating an incumbent supplier.

A CRM opportunity can exist long before the buying organization has committed to making a purchase. When that opportunity fails to close, the board may see a sales execution problem. But the underlying issue may have begun much earlier, when the company failed to understand the customer's business conditions, buying organization, and decision-making process.

This is why the terminology used in a portfolio review matters.

When a CRO reports insufficient qualified leads, I would not immediately conclude that the company has an immature commercial operating model. I would ask what management knows about the potential buyers who have not yet become leads.

If the answer is limited to marketing campaigns, website engagement, prospecting activity, and existing CRM opportunities, the board has reason to examine whether its commercial reporting provides a complete picture of future demand. A pipeline report cannot measure the opportunities a company never identified. And a forecast built primarily on seller activity and opportunity stages is not the same as a forecast grounded in buyer commitment.

6. The CEO's dilemma: Deliver this year's number while rebuilding the system responsible for next year's growth

There is another side to this problem that private equity sponsors need to understand.

A portfolio CEO does not operate with unlimited capital, unlimited time, or unlimited tolerance for short-term underperformance. The CEO may be managing debt obligations, EBITDA commitments, delivery utilization, customer retention, and aggressive organic growth expectations simultaneously. The board expects results. The management team is accountable for delivering them. And when the revenue forecast deteriorates, the pressure to reduce costs and generate immediate pipeline can become overwhelming.

Now consider what happens when the company responds by reducing marketing leadership, restructuring sales, or replacing the CRO. Those interventions may be appropriate when performance or organizational design warrants them. But they may also interrupt account strategies, executive relationships, market intelligence, and institutional knowledge that the company needs to develop future revenue.

A new CRO inherits the existing pipeline, sales organization, marketing capabilities, and customer relationships. The board expects improvement. Yet the new executive may have little control over the commercial decisions made during the preceding 12 to 18 months, including which customers were prioritized, which executive relationships were developed, and which emerging opportunities were overlooked.

The same problem can confront the next CRO. And the next.

At some point, the CEO and the sponsor need to determine whether the issue is executive performance, market conditions, competitive positioning, delivery capability, or the commercial operating system itself. Those explanations are not mutually exclusive.

But replacing executives without examining the underlying system can leave the company vulnerable to repeating the same problems. The CEO's challenge is to develop future demand without abandoning the revenue commitments already in place.

That does not require eliminating lead generation, abandoning CRM, or launching an expensive transformation program. It requires introducing a capability that may be missing from the current operating model: the systematic identification of customers experiencing business conditions that could create demand for the company's services.

The starting point can be a defined group of strategic accounts.

Management can examine what is changing inside those organizations, which executives are responsible for responding, whether the company has relevant relationships, and how those conditions relate to its existing capabilities.

The findings can then be compared with the current pipeline.

Which accounts have meaningful business problems but no active opportunities?
Which forecasted opportunities lack evidence of an organizational commitment to purchase?
Where has the company identified a relevant business problem but failed to establish executive engagement?
And where is the commercial team investing resources in opportunities that have little evidence of a credible buying decision?

This approach can inform immediate account prioritization while building a more repeatable process for identifying future demand. It also gives the CEO a different conversation to have with the board. Rather than simply requesting more marketing investment or additional sales capacity, management can demonstrate where the company has gaps in market intelligence, buying organization access, and commercial execution. The discussion moves from how many leads the company needs to what capabilities are required to deliver the investment thesis.

7. The missing capability: Market sensing and Signal-Led GTM™

This is where I believe private equity firms need to expand their approach to commercial value creation.

Many sponsors already have operating partners with commercial experience. Some have dedicated go-to-market teams, pricing specialists, and revenue-growth advisers. The missing capability is therefore not necessarily another commercial executive. It is a consistent approach to identifying emerging buyer demand before that demand becomes visible through conventional lead generation and CRM reporting.

At Lucrum Partners, we address this through market sensing and Signal-Led GTM™.

Market sensing is the capability to systematically detect and interpret changes in the business environment that may create a need for a company's products or services.

Those changes may be financial, operational, organizational, technological, or competitive. A merger may create a requirement to integrate technology platforms. A new CEO may announce an operating transformation. A CFO may introduce a cost-reduction mandate that creates a need for application rationalization. A company may announce an AI investment that its existing technology infrastructure cannot adequately support.

None of these events proves that a company is ready to purchase software development services. But each provides a reason to investigate whether a material business problem exists, who owns that problem, and whether there is an opportunity to establish a relevant executive conversation.

This is an important distinction from conventional intent data.

Intent data may help identify accounts demonstrating interest in a topic, product category, or solution. Market sensing examines the business conditions that may create the need for a solution in the first place. The objective is not simply to identify who is researching a particular service. It is to understand which organizations may have a problem to solve, why that problem matters, who is responsible for addressing it, and when the organization may need to act.

Signal-Led GTM™ translates that intelligence into a coordinated commercial operating system. The process follows five disciplines: Detect, Interpret, Prioritize, Activate, and Learn.

Market sensing identifies potential demand. Interpretation establishes its business relevance. Prioritization determines where commercial resources should be allocated. Activation coordinates executive engagement, marketing, sales, and account development. Learning evaluates which signals and interventions contribute to meaningful commercial outcomes.

The operating model changes the responsibilities of the revenue organization.

Marketing becomes accountable for market intelligence, early buyer visibility, and building supplier preference, alongside its existing demand-generation responsibilities.

Sales becomes accountable for converting that intelligence into meaningful engagement with buying organizations.
Account management becomes accountable for detecting changing business conditions within existing customers and identifying opportunities to expand those relationships.
The CRO becomes accountable for an integrated commercial operating system rather than simply managing the volume and conversion of leads already entering the funnel.
And the CEO becomes accountable for ensuring that the organization has the capabilities, resources, and governance required to support the company's growth strategy.

This is not a call to eliminate CRM, lead generation, or traditional pipeline management.

It is a call to stop treating them as a complete representation of the addressable revenue opportunity. CRM should help govern the opportunities the company has identified.

Market sensing should help the company identify potential demand that has not yet become an opportunity.

Both capabilities are necessary.

8. The missing piece in private equity's commercial value-creation plan

For the managing director, the question is not simply whether the portfolio company has a capable CRO or an effective marketing organization. It is whether the sponsor has sufficient commercial intelligence to understand how future revenue is being developed.

Many private equity firms conduct extensive commercial due diligence before acquisition.

They assess market size, competitive positioning, customer concentration, retention, pricing, sales effectiveness, and growth opportunities. Those are essential inputs to an investment decision.

But conventional commercial due diligence does not necessarily establish whether a company's operating system can identify emerging customer demand, develop early executive relationships, and influence buying decisions before an active purchasing process begins. That distinction deserves attention.

A portfolio company may operate in an attractive market with strong customer relationships and a compelling service offering. It may have a credible financial plan and an experienced management team. Yet its growth strategy may depend heavily on responding to opportunities after customers have already identified their preferred suppliers.

The sponsor may recognize that the company needs to improve organic growth without recognizing that the underlying commercial system is designed primarily to capture existing demand rather than identify and develop future demand.

I would introduce a commercial operating maturity assessment at four points in the investment lifecycle.

During acquisition diligence: Evaluate how the target company identifies emerging demand, develops executive relationships, understands buying organizations, and builds supplier preference. Determine whether the proposed growth plan is supported by the capabilities needed to deliver it.
During the first 100 days: Establish a baseline of commercial maturity. Assess market sensing, account prioritization, buying organization intelligence, marketing and sales alignment, and forecast governance. Identify which capabilities already exist and which require development.
During quarterly business reviews: Expand the commercial discussion beyond bookings, pipeline coverage, conversion rates, and seller productivity. Require management to demonstrate how the company is identifying emerging demand, developing early executive relationships, and establishing credible buying opportunities.
When commercial performance deteriorates: Before approving another leadership replacement, marketing restructuring, or demand-generation investment, examine whether the underlying problem is market demand, competitive positioning, customer retention, pricing, delivery performance, executive capability, or commercial operating design.

A sponsor should not assume that every missed forecast is evidence of a broken go-to-market model. But it should not assume that replacing the executive responsible for the forecast will resolve the underlying problem, either. The objective is to identify the actual constraint before approving the next intervention.

9. Five questions I would add to the next portfolio review

If I were a managing director reviewing a portfolio company experiencing unstable pipeline, declining conversion, or repeated forecast misses, I would introduce five questions into the next business review.

01 · Market visibility

What percentage of our target accounts have identifiable business conditions that may create demand for our services, and how many of those conditions are we actively monitoring?
Can management identify potential demand independently of inbound leads and existing CRM opportunities?

02 · Early buyer access

Of the qualified opportunities created this quarter, how many originated from our proactive identification of a customer's business problem before the customer formally began evaluating suppliers?
Is the company developing early buyer relationships or primarily responding to demand that has already materialized?

03 · Buying organization intelligence

For our largest forecasted opportunities, can we identify the executive sponsor, economic buyer, competing priorities, approval process, and evidence of organizational commitment?
Does the forecast reflect a credible organizational buying decision or primarily the sales team's confidence in the opportunity?

04 · Commercial resource allocation

How much of our commercial investment is directed toward identifying and influencing future demand versus converting buyers who have already entered an active purchasing process?
Has management deliberately designed and funded both capabilities, or does near-term pipeline pressure determine how resources are allocated?

05 · Forecast integrity

What evidence from the customer's buying organization supports our forecast, and what material events or decisions could prevent each major opportunity from closing?
Can management distinguish between seller activity, customer interest, and demonstrated buyer commitment?

These questions will not eliminate commercial uncertainty. No operating model can guarantee that customers will buy, that every market signal will develop into an opportunity, or that every qualified opportunity will close. But they expose information that conventional pipeline reviews can overlook. They also give the CEO and managing director a common framework for distinguishing between a temporary execution problem and a commercial capability that may require structural intervention. That is where the conversation should begin before approving another round of restructuring.

10. The next private equity growth opportunity may be hiding outside the pipeline

Private equity firms have spent decades building increasingly sophisticated capabilities to improve the businesses they acquire.

The next opportunity is not simply to add another operating partner or recruit a more experienced CRO. It is to ensure that commercial strategy reflects how customers actually make buying decisions and that the resulting operating system is governed with the same discipline as financial performance.

For the CEO, that means building a commercial organization capable of identifying future demand while delivering today's revenue commitments.

For the managing director, it means ensuring that the value-creation plan adequately assesses, funds, and governs that capability.

Neither executive should be satisfied with a growth strategy that begins and ends with generating more leads and improving conversion.

Return to the software development company in our opening example. After six years of ownership, multiple CEO and CRO transitions, repeated cost reductions, and another marketing restructuring, I would want to understand something more fundamental before approving the next intervention.

Is this company failing to generate enough qualified leads?
Or has it spent six years operating a revenue engine that consistently arrives too late to influence the buyer's decision?

The answer has implications well beyond the next quarterly forecast. It goes directly to the sponsor's ability to deliver the original investment thesis. And it is a question that belongs in the private equity boardroom.

Because the most consequential revenue risk may not be the opportunity that slips out of this quarter's forecast. It may be the opportunity that never entered the forecast because the company arrived too late to be considered.

Brian Shea is the founder of Lucrum Partners, a B2B commercial performance advisory firm focused on redesigning go-to-market operating systems around buyer decision science, market sensing, and executive-level selling. Its Signal-Led GTM™ approach helps organizations identify emerging demand, establish earlier buyer engagement, and improve revenue governance.